Thermo Fisher Scientific and Genedata Join Forces to Accelerate Mass Spectrometry-Based Metabolomics Research

Thermo Fisher Scientific Inc., the world leader in serving science, and Genedata, the leading provider of in silico solutions for the pharmaceutical and life sciences industries, today announced the integration of Thermo Scientific mass spectrometry (MS) instrumentation and Genedata Expressionist® to efficiently process and analyze large volumes of high-quality MS data, enabling researchers to process hundreds of gigabytes of data simultaneously.

This capability is particularly beneficial for metabolomics researchers who need to classify samples and identify metabolic profiles related to important biological phenotypes. Genedata Expressionist performs high-throughput processing and automated quality analysis of MS-based metabolomics and proteomics data, enabling researchers to process hundreds of gigabytes of data simultaneously. Genedata Expressionist also includes a sophisticated statistical analysis platform that allows for data comparison. This integrated approach helps researchers to understand the action of all biological molecules in a single, comprehensive system.

Combining Thermo Scientific MS systems with Genedata software solutions, small molecule biomarker detection can be enhanced with an "end-to-end" system that encompasses complete scientific workflows. Dr. Rohan Thakur, director of marketing, small molecule solutions, life sciences mass spectrometry, Thermo Fisher Scientific, explains, “Thermo Scientific instrumentation is ideally suited for metabolomics applications. The unmatched data quality resulting from high-resolution and accurate mass, coupled with the data processing power of Genedata Expressionist, will serve to simplify the search for answers in a fundamentally complex experiment. We believe this powerful combination of hardware and software will enable metabolomics researchers to solve problems faster.”

“Thermo Fisher is a globally recognized leader in mass spectrometry,” said Dr. Othmar Pfannes, CEO of Genedata. “We at Genedata are delighted at the opportunity to help scientists with the challenging process of biomarker discovery and development. Genedata Expressionist enables the simultaneous analysis of large volumes of samples and massive amounts of data, in the hundreds of gigabytes range. The system is metabolomics-ready and scalable, efficiently managing both raw data and extracted peaks. Strong support services and customization to in-house setups round off our MS-based solution.”